These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 35380701

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias.
    Malempati S, Tibbitts D, Cunningham M, Akkari Y, Olson S, Fan G, Sears RC.
    Leukemia; 2006 Sep; 20(9):1572-81. PubMed ID: 16855632
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.
    Pulverer BJ, Fisher C, Vousden K, Littlewood T, Evan G, Woodgett JR.
    Oncogene; 1994 Jan; 9(1):59-70. PubMed ID: 8302604
    [Abstract] [Full Text] [Related]

  • 27. Myc suppression of Nfkb2 accelerates lymphomagenesis.
    Keller U, Huber J, Nilsson JA, Fallahi M, Hall MA, Peschel C, Cleveland JL.
    BMC Cancer; 2010 Jul 02; 10():348. PubMed ID: 20598117
    [Abstract] [Full Text] [Related]

  • 28. Cellular redox homeostasis maintained by malic enzyme 2 is essential for MYC-driven T cell lymphomagenesis.
    Li W, Kou J, Zhang Z, Li H, Li L, Du W.
    Proc Natl Acad Sci U S A; 2023 Jun 06; 120(23):e2217869120. PubMed ID: 37253016
    [Abstract] [Full Text] [Related]

  • 29. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins.
    Smith-Sørensen B, Hijmans EM, Beijersbergen RL, Bernards R.
    J Biol Chem; 1996 Mar 08; 271(10):5513-8. PubMed ID: 8621409
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
    Wang J, Boxer LM.
    J Biol Chem; 2005 Apr 01; 280(13):12766-73. PubMed ID: 15687498
    [Abstract] [Full Text] [Related]

  • 32. MYC activity is negatively regulated by a C-terminal lysine cluster.
    Wasylishen AR, Kalkat M, Kim SS, Pandyra A, Chan PK, Oliveri S, Sedivy E, Konforte D, Bros C, Raught B, Penn LZ.
    Oncogene; 2014 Feb 20; 33(8):1066-72. PubMed ID: 23435422
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X, Carlson NR, Dong J, Zhang Y.
    Oncogene; 2015 Nov 12; 34(46):5709-17. PubMed ID: 25823025
    [Abstract] [Full Text] [Related]

  • 37. Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7.
    Jung JH, Jung DB, Kim H, Lee H, Kang SE, Srivastava SK, Yun M, Kim SH.
    Oncogene; 2018 Jul 12; 37(27):3715-3728. PubMed ID: 29628506
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.